NCT00002968View on ClinicalTrials.gov

Edrecolomab in Treating Patients With Stage II Colon Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

2,100

Participants

Timeline

Start Date

May 31, 1997

Primary Completion Date

July 31, 2003

Conditions
Mucinous Adenocarcinoma of the ColonSignet Ring Adenocarcinoma of the ColonStage IIA Colon CancerStage IIB Colon CancerStage IIC Colon Cancer
Interventions
BIOLOGICAL

edrecolomab

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

60606

Cancer and Leukemia Group B, Chicago

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00002968 - Edrecolomab in Treating Patients With Stage II Colon Cancer | Biotech Hunter | Biotech Hunter